Skip to content
★ Sign in to follow
AC

AlphaPurchase Corporation Stock: price and insider trades · Japan

株式会社アルファパーチェス

JP·Mcap JP¥13.8BHealth Care

AlphaPurchase Corporation: what insiders have been doing

AlphaPurchase Corporation has a thin disclosure history in our data (latest filing: 27 December 2022). New filings will appear here as soon as they are published. These figures are compiled from regulatory filings published by EDINET (Japan FSA). They describe what insiders did and are not a recommendation.

Insider Decl.
2
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 8,424 of 26,911 companies
60.9
score / 100
Value
65
Quality
56
FCF yld0.1%
Earn yld7.5%
EV/EBITDA6.4x
ROE16%
Gross mgn10%
Net mgn1.8%
Debt/EBITDA0.0x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

JP¥1,406
Analyst consensus
·
Income statement
RevenueJP¥58.9B
Gross profitJP¥6.1B10% margin
EBITDAJP¥2.2B4% margin
Net incomeJP¥1B1.7% margin
Valuation
PER (trailing)13.6x
P/Book2.0x
Beta0.37
Balance sheet & cash
Market capJP¥13.8B
Total debtJP¥3.4M
Free Cash FlowJP¥10M
Profitability & ownership
ROE15.9%
ROA5.7%
% insiders75.8%
% institutions2.2%
Last declaration on 27 December 2022
Declarations2 total
  • ●
    Related company / holdingExecutives
    13EDINET
    100.0% of flowShareXTKSEDINET:S100PU8P
  • ●
    Related company / holdingExecutives
    13EDINET
    100.0% of flowShareXTKSEDINET:S100PVY5

2 of 2 declarations

About AlphaPurchase Corporation

株式会社アルファパーチェス is a company specializing in the healthcare and pharmaceutical sector. It is listed on the XTKS market.